I hope I am wrong but once we get Ryoncil approval, the precedence and pathway will be set for a much easier approval process for all its other indications. Subsequently Big Pharma will swallow us up and never allow this company to reach its full value on the ASX.
Only way to remove some of this risk is if a fund buys 10+ % and they hold out strong with Gregory George and SI. These two are long term investors and full believers of the potential.
Mesoblast stock(rock)-take March 2024, page-8
-
- There are more pages in this discussion • 266 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.065(6.07%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 99.5¢ | $9.449M | 9.298M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 64999 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 64541 | 3 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |